Saudi Arabia Biopharmaceutical Market Size & Outlook
Related Markets
Saudi Arabia biopharmaceutical market highlights
- The Saudi Arabia biopharmaceutical market generated a revenue of USD 1,668.0 million in 2025 and is expected to reach USD 2,509.2 million by 2033.
- The Saudi Arabia market is expected to grow at a CAGR of 5% from 2026 to 2033.
- In terms of segment, monoclonal antibody was the largest revenue generating molecule type in 2025.
- Hormone is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Biopharmaceutical market data book summary
| Market revenue in 2025 | USD 1,668.0 million |
| Market revenue in 2033 | USD 2,509.2 million |
| Growth rate | 5% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibody |
| Fastest growing segment | Hormone |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone |
| Key market players worldwide | F. Hoffmann-La Roche Ltd., Novartis AG ADR, AbbVie Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Bristol-Myers Squibb Company, Sanofi SA, GSK PLC ADR, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Biogen Inc, Eli Lilly and Company, Novo Nordisk A/S ADR, Amgen Inc. |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.3% of the global biopharmaceutical market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, Saudi Arabia biopharmaceutical market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1,126.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Market Scope
Biopharmaceutical Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Amgen Inc. | View profile | - | - | - |
| Eli Lilly and Company | View profile | - | - | - |
| Merck & Co., Inc. | View profile | - | - | - |
| Johnson & Johnson Services, Inc. | View profile | - | - | - |
| Takeda Pharmaceutical Company Limited | View profile | - | - | - |
| Bristol-Myers Squibb Company | View profile | - | - | - |
| Pfizer Inc. | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| AbbVie Inc. | View profile | - | - | - |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Saudi Arabia biopharmaceutical market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical market will help companies and investors design strategic landscapes.
Monoclonal antibody was the largest segment with a revenue share of 68.02% in 2025. Horizon Databook has segmented the Saudi Arabia biopharmaceutical market based on monoclonal antibody, interferon, insulin, growth and coagulation factor, erythropoietin, vaccine, hormone covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Saudi Arabia biopharmaceutical market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia biopharmaceutical market databook
-
Our clientele includes a mix of biopharmaceutical market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia biopharmaceutical market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia biopharmaceutical market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia biopharmaceutical market size, by molecule type, 2021-2033 (US$M)
Saudi Arabia Biopharmaceutical Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
